ArticleJAMA network open2021

Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019.

Meera Dhodapkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.